tirzepatide mesquite tx Houston, Tirzepatide Weight Loss Houston |

4 However, an analysis of this study showed that there was no difference in cardiovascular events between the intensive intervention group and the diabetes support and education group

Discussion As the use of GLP-1 RAs continues to rise in the US for both diabetes and obesity management ( 1 , 2 ), understanding why patients discontinue these therapies is critical for improving long-term treatment outcomes

The drugs mimic GLP-1, a hormone the body produces after eating, which can decrease appetite and help the body manage insulin production

The local authorities and medical ethical review board of the VU University Medical Center (Amsterdam, The Netherlands METc no

Some people experience severe gastrointestinal distress that makes the medication intolerable